Rates of faecal colonization by carbapenemase-producing enterobacteriaceae among patients admitted to ICUs in Spain

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 10, 2015, Pages 2916-2918

  Oteo, Jesús ^a   Alcaraz, Rosa ^b   Bou, Germán ^c   Conejo, Carmen ^d   Díaz lamas, Ana María ^c   Fernández martínez, Marta ^e   Fontanals, Dionisia ^f   González lópez, Juan José ^b   López contreras, Joaquín ^g   Martínez martínez, Luis ^e   Mora rillo, Marta ^h   Muñoz, María ⁱ   Navarro, Ferran ^g   Oliver, Antonio ^j   Pintado, Vicente ^k   Ruiz carrascoso, Guillermo ^h   Ruiz garbajosa, Patricia ^k   Sánchez porto, Antonio ^l   Sánchez romero, Isabel ⁱ   Zamorano, Laura ^j   Aracil, Belén ^a   Rodríguez baño, Jesús ^d   more..

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL JUAN CANALEJO   (Spain)

^d UNIVERSITY OF SEVILLE   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f Servicio de Oncología Médica   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

ⁱ HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k HOSPITAL RAMÓN Y CAJAL   (Spain)

^l Hospital del SAS   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BETA LACTAMASE OXA 48; MEROPENEM; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CARBAPENEMASE;

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CLINICAL ARTICLE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FECES; FECES ANALYSIS; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA OXYTOCA; LETTER; NONHUMAN; OBSERVATIONAL STUDY; SPAIN; BIOSYNTHESIS; CLASSIFICATION; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; MICROBIOLOGY; PREVALENCE;

BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; HUMANS; INTENSIVE CARE UNITS; PREVALENCE; SPAIN;

EID: 84943746674     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv187     Document Type: Letter

References (12)

1. Oteo J, Ortega A, Bartolomé R et al. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem. Antimicrob Agents Chemother 2015; 59: 3406-12.
2. Tzouvelekis LS, Markogiannakis A, Piperaki E et al. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2014; 20: 862-2.
3. Papadimitriou-Olivgeris M, Marangos M, Fligou F et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 2012; 67: 2976-81.
4. Debby BD, Ganor O, Yasmin M et al. Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis 2012; 31: 1811-7.
5. International Organization for Standardization (ISO). Clinical Laboratory Testing and In Vitro Diagnostic Test Systems-Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices. Part 1: Reference Method for Testing the In Vitro Activity of Antimicrobial Agents against Rapidly Growing Aerobic Bacteria Involved in Infectious Diseases. International Standard 20776-1. Geneva: ISO, 2006.
6. EUCAST Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance, Version 1.0, December 2013. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance:mechanisms/EUCAST_detection_of_resistance:mechanisms_v1.0_20131211.pdf.
7. Oteo J, Saez D, Bautista V et al. Carbapenemase-producing Enterobacteriaceae in Spain in 2012. Antimicrob Agents Chemother 2013; 57: 6344-7.
8. Kim J, Lee JY, Kim SI et al. Rates of fecal transmission of extended-spectrum b-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med 2014; 34: 20-5.
9. Paño-Pardo JR, Ruiz-Carrascoso G, Navarro-San Francisco C et al. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak. J Antimicrob Chemother 2013; 68: 89-96.
10. Sánchez-Romero I, Asensio A, Oteo J et al. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 2012; 56: 420-7.
11. Coelho A, Piedra-Carrasco N, Bartolomé R et al. Role of IncHI2 plasmids harbouring blaVIM-1, blaCTX-M-9, aac(6')-Ib and qnrA genes in the spread of multiresistant Enterobacter cloacae and Klebsiella pneumoniae strains in different units at Hospital Vall d'Hebron, Barcelona, Spain. Int J Antimicrob Agents 2012; 39: 514-7.
12. Tacconelli E, Cataldo MA, Dancer SJ et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect; 2014; 20 Suppl 1: 1-55.